Høgdall, C. K. (1996) “Use of Tetranectin, CA-125 and Casa to Predict Residual Tumor and Survival at Second- and Third-Look Operations for Ovarian Cancer”, Acta Oncologica, 35(1), pp. 63–69. doi: 10.3109/02841869609098481.